Vanessa Carle's most recent trade in Lexaria Bioscience Corp was a trade of 15,000 Stock Options done . Disclosure was reported to the exchange on May 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 15,000 | 75,000 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 31 Jul 2024 | 2,567 | 0 | - | 4 | 10,268 | common shares |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share. | 14 May 2024 | 2,500 | 2,567 | - | 1.2 | 2,875 | common shares |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 2,500 | 60,067 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 10,000 | 62,567 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 12,500 | 40,067 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 10,000 | 27,567 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 5,000 | 17,567 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Other type of transaction at price $ 0.00 per share. | 07 May 2021 | 5,000 | 12,567 | - | - | Stock Options | |
Lexaria Bioscience Corp | Vanessa Carle | Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 12,500 | 17,567 | - | - | Stock Options |